The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,545.00
Bid: 3,530.00
Ask: 3,545.00
Change: 10.00 (0.28%)
Spread: 15.00 (0.425%)
Open: 3,560.00
High: 3,560.00
Low: 3,535.00
Prev. Close: 3,535.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

7 Oct 2020 12:00

RNS Number : 3951B
Caledonia Investments PLC
07 October 2020
 

Caledonia Investments plc

 

Unaudited net asset value and portfolio update

 

Caledonia Investments plc ("Caledonia") announces its unaudited diluted net asset value per share ("NAV") as at 30 September 2020, calculated on a cum-income basis, was 3528p. This incorporates the biannual revaluation of the Private Capital portfolio and reassessment of the Funds valuations.

 

The NAV total return for the six months to 30 September 2020 was 10.5%. A final dividend of 44.5p per ordinary share for the year ended 31 March 2020 was paid to shareholders on 6 August 2020. This announcement provides a further update on Caledonia's portfolio and should be read in conjunction with the factsheet dated 30 September 2020 and released on 7 October 2020, a copy of which is available at www.caledonia.com.

 

Summary

 

The increase in NAV in the period was driven by the strong performance of the Quoted Equity pool, together with reassessment of the Covid-19 impact on Funds investments, based on updated managers' NAV and removal of the adjustment to reflect the impact of Covid-19, introduced at 31 March 2020. The businesses within the Private Capital portfolio were also revalued, which resulted in a small increase in NAV.

 

Support for investee companies has continued, including the provision of capital for acquisitions and, for one business, as part of a recapitalisation. The Funds pool witnessed a significant slowdown in merger and acquisition activity and caution by fund managers to provide sufficient liquidity to manage the impact of Covid-19. Caledonia had a net cash outflow of £122m in the six month period.

 

Total liquidity remains satisfactory with £243m available as at 30 September 2020, comprising £8m in cash and £235m of undrawn committed bank facilities. Our £250m banking facilities comprise £137.5m expiring in May 2025 and the balance of £112.5m in July 2022. £15m was drawn from these facilities in late September.

 

Performance for the first half is summarised in the table below:

 

Caledonia pool performance

Net asset value - Half Year to 30 September 2020

 

£m

 

 

Opening

balance

Net

investment

/(disposal)

Capital

gains /

(losses)

Other

Closing

balance

Income

Total

Return

Quoted Equity

574.0

6.8

118.0

-

698.8

9.2

22.2%

Private Capital

611.3

47.1

0.5

(1.9)

657.0

6.3

1.1%

Funds

450.1

43.7

74.3

-

568.1

0.1

15.7%

Portfolio

1,635.4

97.6

192.8

(1.9)

1,923.9

15.6

Net Cash

Other assets

114.7

37.2

(97.6)

-

-

-

(24.5)

6.4

(7.4)

43.6

Net assets

1,787.3

-

192.8

(20.0)

1,960.1

NAVTR

10.5%

 

(Net Cash - Other: includes final dividend of £24.4m paid on 6 August 2020)

 

Caledonia's March 2020 NAV incorporated additional discounts within the valuations of both the Private Capital and Funds portfolios to account for the potential impact of Covid-19. Whilst the impact of Covid-19 continues to create a degree of uncertainty, the businesses have adapted to the new environment and the trading outlook is clearer than it was in March.

 

In the Private Capital portfolio, the majority of the business have been valued on a normalised earnings multiple basis, with a Covid-19 adjustment applied only to Liberation Group, where, despite robust trading following the easing of restrictions implemented in response to the pandemic, the impact of further local and national constraints on the UK pub business remains a concern.

 

In the Funds portfolio, where available, we have used 30 June 2020 manager valuations covering 84% of the value of the holdings. The remaining funds, principally several Aberdeen US private equity funds, are based on 31 March valuations. In light of the receipt of these more recent valuations, we no longer apply an adjustment to reflect the Covid-19 risk, as we did at March 2020.

 

Caledonia Quoted Equity - Capital and Income portfolios (36% of NAV)

 

The total return of the Quoted Equity portfolio was 22.2% over the first half of the year. This strong performance reflected a notable rebound in global public equity markets and careful stock selection within both the Capital and Income portfolios. The total returns were 26.2% and 11.1% respectively, building on the performance for the year to 31 March 2020 during which both portfolios proved resilient, falling by just 0.3% compared to the falls in the FTSE All-Share of -18.5% and the S+P 500 of -9.9%.

 

Trading activity during the period was limited. The development of the Income portfolio continued with the addition of a position in Fortis Inc, a North American utilities business, and the disposal of the holding in Tritax Big Box. Other activity was restricted to refining positions in existing investments, in line with Caledonia's strategy of owning high quality companies that compound their earnings over the long term.

 

Caledonia Private Capital (33% of NAV)

 

Caledonia's diverse Private Capital portfolio includes significant positions in six UK based businesses and one private European investment company. These seven investments represent over 90% of its value. The portfolio generated total return of 1.1% during the first half of the year. The industrial and financial services businesses have adapted well to the new Covid-19 trading environment. The impact of the pandemic on our two consumer facing businesses, Buzz Bingo and Liberation Group, has been felt more acutely. The investment in Cobehold continues to perform well.

 

Buzz Bingo, the UK's biggest omni-channel bingo business, completed a company voluntary arrangement ("CVA") process in August 2020 to protect the long-term prospects of the business, leading to the closure of 26 clubs and, regrettably, associated redundancies. Caledonia participated in the CVA process with the provision of £22m in new equity. The business commenced the phased reopening of its retail venues from early August with all remaining clubs now open. Retail trading post re-opening has been ahead of expectations with the online business (www.buzzbingo.com) now profitable on a monthly basis and continuing to grow player numbers. Valuation at 30 September £22.0m, down 46% from March 2020.

 

Liberation Group, a pub, restaurant and drinks business with operations in the Channel Islands and the South West of the UK, gradually reopened its pub estate from the middle of June. 95 of the 104 pubs are now open and have traded well through the summer, with weekly revenues building to levels close to, or in some cases ahead of, those achieved in 2019. It is anticipated that the recent change to pub opening hours in the UK will have limited impact on trading, with venues in the Channel Islands unaffected. The UK brewery operated throughout the period, supporting trade and growing online sales. The wholesale businesses in Jersey and Guernsey remained open and traded strongly. Valuation at 30 September £59.8m, up 18% from March 2020.

 

Seven Investment Management ("7IM"), the retail investment manager, has traded well during the period. Assets under management ("AUM") have grown to £14.8bn, ahead of the January 2020 position, due to market performance and positive fund inflows. 7IM's range of funds continue to perform strongly, with core funds in the first and second quartiles over one and three years compared to their peers. 7IM completed the acquisition of Partners Wealth Management, a high-net worth financial planning business, at the end of September. Valuation at 30 September £104.1m, up 23% from March 2020.

 

Deep Sea Electronics ("DSE"), the industry leading manufacturer of genset and ATS control modules, battery chargers and power supplies, has remained operational throughout the period. DSE has traded well, continuing to be strongly cash generative. Opportunities for organic growth and bolt-on acquisitions are being actively explored. Valuation at 30 September £131.6m, up 7% from March 2020.

 

Cooke Optics, a leading manufacturer of cinematography lenses, has been adversely impacted by the Covid-19 pandemic. In April, Cooke temporarily closed its facilities to develop a safe working environment for employees, before quickly returning to full capacity. Filming activity has been restricted across most geographies, however the business remains profitable with a healthy order book and, with long-term demand for high quality content expected to remain strong, is well placed to respond as demand recovers. Valuation at 30 September £78.5m, up 3% from March 2020.

 

Stonehage Fleming, the international family office, continues to trade strongly adhering to local working practices across the jurisdictions in which it operates. Activity levels remain high along with AUM increasing by 11% since March 2020 to £12.5bn. In July 2020, Stonehage Fleming successfully acquired Cavendish Asset Management in an all share transaction, adding a further £1bn of AUM. Valuation at 30 September £101.7m, up 14% from March 2020.

 

Cobepa, the Belgian based investment company, owns a diverse portfolio of private global investments. Certain of its businesses impacted by Covid-19 are now returning to more normal trading levels. The valuation of Cobehold, the holding company of Cobepa, reflects this more positive outlook and the removal of the Covid-19 discount resulted in a valuation at 30 September of £105.5m, up 8% from March 2020.

 

Caledonia Funds (29% of NAV)

 

The total return on the Funds portfolio was 15.7% over the first half of the year. This reflects underlying fund performance and reverting to basing valuations on managers' NAV, without the need to adjust to reflect the Covid-19 impact as we did at March 2020. Updated valuations dated 30 June 2020, amounting to 84% of the Funds NAV, have been incorporated. This excludes the holdings in Aberdeen US private equity funds which remain at the manager's 31 March 2020 valuation, representing 16% of the Funds NAV.

 

Caledonia's fund investments are principally in third party managed private equity funds operating in the US and in Asia. Regular contact is maintained with the fund managers to understand the performance of their investee businesses. The overview they provide has gradually improved during the last six months, with the majority of businesses progressing in line with their pre-Covid plans with relatively few having witnessed a notable decline in trading. Asian fund investments have performed well, showing modest growth over the period and notable gains for healthcare related businesses. In contrast, US funds show some underlying valuation reductions which reflect the continuing impact of Covid-19 and the sector mix within the investee businesses. During the first half of the year, £57.8m was invested and distributions of £14.1m were received.

 

 

Company contacts

Caledonia Investments plc  +44 20 7802 8080

Will Wyatt,

Chief Executive

 

Tim Livett,

Chief Financial Officer

 

Media contacts

Tulchan Communications  +44 20 7353 4200

Tom Murray

Lisa Jarrett-Kerr

caledonia@tulchangroup.com

 

7 October 2020

Notes

 

Valuation approach and methodology

 

The valuation approach utilised for each asset portfolio is summarised below.

 

Caledonia Quoted Equity: all listed companies are valued based on the closing bid price on the relevant exchange as at 30 September 2020.

 

Caledonia Private Capital: the holdings are valued biannually, on a normalised EBITDA x market multiple basis where appropriate (in line with the latest IPEV guidelines). This approach was applied to the majority of the portfolio at 30 September 2020, with the following amendments:

 

A. Trading in the current year has been heavily impacted by Covid-19 for a number of businesses in the portfolio. Valuations would use normalised LTM EBITDA as a key input under standard circumstances; however, we have also used historic and forecast earnings information in order to address this issue and provide a more balanced view of valuation.

 

B. The approach to valuation has incorporated the trading impact from Covid-19 seen in the first half of the year and the likely recovery looking forward. However, for one of our consumer businesses, Liberation Group, new restrictions have recently been imposed. This uncertainty is not fully reflected in our valuation and, therefore, a further equity valuation reduction was applied based on the anticipated severity of impact (in this case 10%).

 

Caledonia Funds: the fund valuations are based on the most recent valuations provided by the fund managers, subject to cash movements from the valuation date. Valuations are received 60 to 180 days from the valuation date. This approach, which has been applied for 30 September 2020 valuations, is in contrast to the year ended 31 March 2020 when a Covid-19 adjustment was applied to December 2019 fund managers' NAVs in light of the uncertainty created by the pandemic.

 

Caledonia Investments plc

 

Caledonia is a self-managed investment trust company. Its aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid permanent loss of capital. This is achieved by investing in proven well-managed businesses that combine long term growth characteristics with an ability to deliver increasing levels of income. Investments are held in both listed and private markets, a range of sectors and, particularly through the fund investments, with a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBDLFBBBLZFBF
Date   Source Headline
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.